Updated Jul 16, 2026 · Last SEC filing 2025-04-21
Enfusion, Inc. (ENFN) — no SEC Form 4 insider filings recorded in the last 90 days. InsiderAlpha tracks every ENFN SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001868912 |
|---|
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| LEIBOWITZ LAWRENCE E | Director | D — Derivative transaction | 175.6K | — | — | SEC | |
| Herring Bradley | Chief Financial Officer | S — Open-market sale | 24.4K | $10.61 | $259K | SEC | |
| Pawar Neal | Chief Operating Officer | S — Open-market sale | 26.2K | $10.09 | $265K | SEC | |
| Pawar Neal | Chief Operating Officer | S — Open-market sale | 21.8K | $10.03 | $219K | SEC | |
| Pawar Neal | Chief Operating Officer | S — Open-market sale | 19.2K | $9.92 | $191K | SEC | |
| Campobasso Matthew | General Counsel | S — Open-market sale | 674 | $8.95 | $6K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Enfusion, Inc. (ENFN). Updated in real time as new filings are submitted to the SEC.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ENFN insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live ENFN dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.